A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors

Author： Hilgers Werner   Faivre Sandrine   Chieze Stéphanie   Alexandre Jérôme   Lokiec François   Goldwasser François   Raymond Eric   Kahatt Carmen   Taamma Abdelkrim   Weems Garry   MacDonald John   Misset Jean-Louis   Cvitkovic Esteban  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.24, Iss.4, 2006-07, pp. : 311-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I and pharmacokinetic study of Bay 38-3441, a camptothecin glycoconjugate, administered as a 30-minute infusion daily for five days every 3 weeks in patients with advanced solid malignancies

By Chen Eric   Batist Gerald   Siu Lillian   Bangash Naeema   Maclean Martha   McIntosh Lynn   Miller Wilson   Oza Amit   Lathia Chetan   Petrenciuc Oana   Seymour Lesley  

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 455-465

Springer Publishing Company

Access to resources Recommend Favorite

A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors

By Delaunoit Thierry   Burch Patrick   Reid Joel   Camoriano John   Kobayash Tomowo   Braich Theodore   Kaur Judith   Rubin Joseph   Erlichman Charles  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 327-333

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of Vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks

By Johnson Peter   Geldart Thomas   Fumoleau Pierre   Pinel Marie-Claire   Nguyen Laurent   Judson Ian  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 223-231

Springer Publishing Company

Access to resources Recommend Favorite

A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumors

By Heath Elisabeth  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1566-1574

Springer Publishing Company

Access to resources Recommend Favorite

Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-study

By Schmid Peter   Schweigert Marcus   Beinert Thomas   Flath Bernd   Sezer Orhan   Possinger Kurt  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 139-146

Springer Publishing Company

Access to resources Recommend Favorite